MktsMarkets

BioLife Solutions, Inc.
NASDAQ: BLFSKey statistics
BLFS News
Stories mentioning BLFS from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | 10,004 | 7,254 | ||||||
| Gross Profit | 17,496 | 47,318 | 0.00 | 0.00 | 14,800 | 50,096 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 2,650 | 699.00 | 2,709 | 2,719 | 1,439 | (1,246) | 1,893 | 2,029 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 27.00 | 629.00 | (89.00) | (16,643) | (499.00) | 542.00 | (418.00) | (1,306) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 180.00 | 1,183 | 284.00 | 247.00 | 101.00 | (2.00) | 97.00 | 146.00 |
| Pretax Income | 1,248 | 2,643 | 703.00 | (15,712) | 285.00 | 469.00 | (551.00) | (5,559) |
| Tax Provision | 62.00 | (173.00) | 82.00 | 126.00 | 14.00 | 24.00 | (80.00) | 1.00 |
| Net Income (Loss) | 1,186 | 11,070 | 621.00 | (15,838) | (448.00) | 12,459 | (1,703) | (20,719) |
| Earnings Per Share (Basic) | 0.02 | 0.23 | 0.01 | (0.33) | (0.01) | 0.27 | (0.04) | (0.45) |
| Earnings Per Share (Diluted) | 0.02 | 0.23 | 0.01 | (0.33) | 0.00 | 0.27 | (0.04) | (0.45) |
| Weighted Average Shares Outstanding (Basic) | 48,459 | 47,754 | 47,925 | 47,798 | 47,135 | 46,067 | 46,175 | 46,004 |
| Weighted Average Shares Outstanding (Diluted) | 49,248 | 48,645 | 48,724 | 47,798 | 48,368 | 46,067 | 46,175 | 46,004 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BLFS
BioLife Solutions, Inc. (NASDAQ: BLFS) is a stock listed on the Nasdaq Stock Market under the ticker symbol BLFS. It last traded at $38.61 (Oct 4, 2026, 8:00 PM ET), up 3.5% on the day. That gives BioLife Solutions a market capitalisation of $1.9B and a price-to-earnings ratio of 32.6.
Over the past 52 weeks BLFS has traded between $17.86 and $39.76.
Net income for the quarter ended Mar 31, 2026 was $1.2M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | $1.2M |
| Dec 31, 2025 | — | $11.1M |
| Sep 30, 2025 | — | $621.0K |
| Jun 30, 2025 | — | -$15.8M |
From BioLife Solutions’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…